ARTICLE | Finance
Plus: New funds for Sands and NewVale, and series C rounds for Lycia and Ajax
By Paul Bonanos, Director of Biopharma Intelligence
May 16, 2024 9:25 PM UTC
An immunology start-up emerged from stealth with a large commitment from Blackstone, and two firms announced new funds this week to foster biotech start-ups’ growth.
Blackstone Life Sciences has committed up to $300 million to newly launched Uniquity Bio Inc., a company advancing an antibody that could have advantages over others in the anti-TSLP class to treat immune and inflammatory diseases, starting with COPD and asthma…
- SEO Powered Content & PR Distribution. Get Amplified Today.
- PlatoData.Network Vertical Generative Ai. Empower Yourself. Access Here.
- PlatoAiStream. Web3 Intelligence. Knowledge Amplified. Access Here.
- PlatoESG. Carbon, CleanTech, Energy, Environment, Solar, Waste Management. Access Here.
- PlatoHealth. Biotech and Clinical Trials Intelligence. Access Here.
- Source: https://www.biocentury.com/article/652440/venture-report-blackstone-eyes-pipeline-in-a-product-via-uniquity-launch